Onderzoeker
Robbe Van den Begin
- Trefwoorden:Geneeskunde
Affiliaties
- Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf8 dec 2017 → 10 jul 2018 - Radiotherapie (Departement)
Lid
Vanaf1 dec 2014 → 15 jul 2018 - Radiotherapie (Departement)
Lid
Vanaf18 aug 2011 → 31 aug 2014 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf17 aug 2011 → 29 jun 2016 - Faculteit van de Geneeskunde en Farmacie (Faculteit)
Lid
Vanaf22 sep 2007 → 8 jul 2011
Publicaties
1 - 10 van 23
- The METABANK score(2019)
Auteurs: Robbe Van den Begin, Benedikt Engels, Christine Collen, Tessa de Vin, Arne Defauw, Emilie Dubaere, Kurt Barbé, Mark De Ridder
Pagina's: 113-119 - Successful treatment with intralesional talimogene laherparepvec in two patients with immune checkpoint inhibitor-refractory, advanced-stage melanoma(2019)
Auteurs: Teofila Seremet, Simon Planken, Julia Katharina Schwarze, Yanina Jansen, Laura Vandeweerd, Robbe Van den Begin, Ioannis Tsechelidis, Danielle Lienard, Veronique Del Marmol, Bart Neyns
Pagina's: 85-88 - MRI-based tumor inter-fraction motion statistics for rectal cancer boost radiotherapy(2019)
Auteurs: Jean-Paul J E Kleijnen, Bram van Asselen, Robbe Van den Begin, Martijn Intven, Johannes P M Burbach, Onne Reerink, Marielle E P Philippens, Mark De Ridder, Jan J W Lagendijk, Bas W Raaymakers
Pagina's: 232-236 - Improving precision in Stereotactic Body Radiotherapy for oligometastatic disease.(2019)
Auteurs: Robbe Van den Begin, Benedikt Engels, Mark De Ridder
- Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab(2018)
Auteurs: Stephanie Du Four, Yanina Jansen, Alex Michotte, A Vanbinst, Robbe Van den Begin, Johnny Duerinck, Bart Neyns
Pagina's: 4870-4879 - Tumor volume regression during preoperative chemoradiotherapy for rectal cancer(2018)
Auteurs: Robbe Van den Begin, Jean-Paul Kleijnen, Benedikt Engels, Marielle Philippens, Bram van Asselen, Bas Raaymakers, Onne Reerink, Mark De Ridder, Martijn Intven
Pagina's: 723-727 - The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients(2018)
Auteurs: O C Guler, Benedikt Engels, C Onal, Hendrik Everaert, Robbe Van den Begin, Thierry Gevaert, Mark De Ridder
Pagina's: 484-490 - The long- and short-term variability of breathing induced tumor motion in lung and liver over the course of a radiotherapy treatment(2018)
Auteurs: Jennifer Dhont, Jef Vandemeulebroucke, Nicoleta Manuela Burghelea, Kenneth Poels, Tom Depuydt, Robbe Van den Begin, Cyril Jaudet, Christine Collen, Benedikt Engels, Truus Reynders, et al.
Pagina's: 339-346 - Treating patients with Dynamic Wave Arc(2017)
Auteurs: Nicoleta Manuela Burghelea, Dirk Verellen, Jennifer Dhont, Cecilia Hung, Thierry Gevaert, Robbe Van den Begin, Christine Collen, Kenneth Poels, Koen Tournel, Marlies Boussaer, et al.
Pagina's: 347-351 - Treating patients with Dynamic Wave Arc: First clinical experience(2017)
Auteurs: Nicoleta Manuela Burghelea, Dirk Verellen, Jennifer Dhont, Cecilia Hung, Robbe Van den Begin, Christine Collen, Kenneth Poels, Koen Tournel, Marlies Boussaer, Cyril Jaudet, et al.
Pagina's: 347-351